Unanticipated role of apelin: Regulation of miRNA generation

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 10, 2013, Pages 896-898

  Lv, Deguan ^a   Lu, Qixuan ^a   Cao, Jiangang ^a   Chen, Linxi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MICRORNA; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; HUMAN; METABOLISM; PULMONARY HYPERTENSION;

ANIMALS; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPERTENSION, PULMONARY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS;

EID: 84888632473     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt090     Document Type: Article

References (17)

1. Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA and McLean DL, et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 2013, 19: 74-82.
2. Alastalo TP, Li M, Perez Vde J, Pham D, Sawada H, Wang JK and Koskenvuo M, et al. Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest 2011, 121: 3735-3746.
3. Tu L, De Man FS, Girerd B, Huertas A, Chaumais MC, Lecerf F and Francois C, et al. A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. Am J Respir Crit Care Med 2012, 186: 666-676.
4. Tu L, Dewachter L, Gore B, Fadel E, Dartevelle P, Simonneau G and Humbert M, et al. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol 2011, 45: 311-322.
5. Bockmeyer CL, Maegel L, Janciauskiene S, Rische J, Lehmann U, Maus UA and Nickel N, et al. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant 2012, 31: 764-772.
6. Han S, Wang G, Qi X, Lee HM, Englander EW and Greeley GH, Jr. A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regul Integr Comp Physiol 2008, 294: R1832-R1839.
7. Geiger K, Muendlein A, Stark N, Saely CH, Wabitsch M, Fraunberger P and Drexel H. Hypoxia induces apelin expression in human adipocytes. Horm Metab Res 2011, 43: 380-385.
8. Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J and Fernandez M. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol 2009, 50: 296-305.
9. Lv D, Li H and Chen L. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis. Acta Biochim Biophys Sin 2013, 45: 527-533.
10. Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH, Kwon YD and Lee C, et al. MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res 2013, 6: 18.
11. Hewagama A, Gorelik G, Patel D, Liyanarachchi P, Joseph McCune W, Somers E and Gonzalez-Rivera T, et al. Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun 2013, 41: 60-71.
12. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R and Zheng L, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008, 118: 3343-3354.
13. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H and Ishida J, et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007, 171: 1705 -1712.
14. Liu C, Su T, Li F, Li L, Qin X, Pan Wand Feng F, et al. PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13. Acta Biochim Biophys Sin 2010, 42: 396-402.
15. Li X, Zhang X, Li F, Chen L, Li L, Qin X and Gao J, et al. 14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells. Acta Biochim Biophys Sin 2010, 42: 403-409.
16. Munoz-Pacheco P, Ortega-Hernandez A, Miana M, Cachofeiro V, Fernandez- Cruz A and Gomez-Garre D. Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel antiatherosclerotic mechanism. Pharmacol Res 2012, 66: 536-543.
17. Manavella PA, Hagmann J, Ott F, Laubinger S, Franz M, Macek B and Weigel D. Fast-forward genetics identifies plant CPL phosphatases as regulators of miRNA processing factor HYL1. Cell 2012, 151: 859-870.